[聚焦慢性乙型肝炎病毒感染的监测及抗病毒治疗标志物] - Suppr

Suppr

超能文献

[Focusing on the markers for monitoring and antiviral therapy in chronic hepatitis B virus infection].

作者信息

Wei Lai

机构信息

People's Hospital, Hepatology Institute, Peking University, Beijing 100044, China.

出版信息

Zhonghua Gan Zang Bing Za Zhi. 2006 Nov;14(11):836-7.

PMID:17125613

Abstract

摘要

相似文献

[Focusing on the markers for monitoring and antiviral therapy in chronic hepatitis B virus infection].

Zhonghua Gan Zang Bing Za Zhi. 2006 Nov;14(11):836-7.

Sequential combination therapy for chronic hepatitis B: more challenges to be tackled.

Am J Gastroenterol. 2007 Jul;102(7):1544; author reply 1545. doi: 10.1111/j.1572-0241.2007.01261.x.

[The genetic variability and clinical significance of hepatitis B virus].

Zhonghua Gan Zang Bing Za Zhi. 2009 Mar;17(3):161-3.

[HBV mutations during antiviral therapy in patients with chronic hepatitis B].

Korean J Hepatol. 2005 Dec;11(4):311-9.

Antiviral therapy of chronic hepatitis B.

Antiviral Res. 2006 Sep;71(2-3):206-15. doi: 10.1016/j.antiviral.2006.04.003. Epub 2006 Apr 25.

[Effects of lamivudine and interferon-alpha combination therapy on chronic hepatitis B].

Zhonghua Gan Zang Bing Za Zhi. 2002 Apr;10(2):89.

Events occurring at the time of breakthrough hepatitis during lamivudine treatment for chronic hepatitis B.

J Gastroenterol. 2004 Aug;39(8):813-4. doi: 10.1007/s00535-004-1415-9.

Management of antiviral resistance in patients with chronic hepatitis B.

Antivir Ther. 2004 Oct;9(5):679-93.

[Therapy effects of short-term lamivudine treatment on 22 hepatitis B patients with HBeAg-negative].

Zhonghua Gan Zang Bing Za Zhi. 2003 Apr;11(4):239.

Revisiting the treatment recommendations for chronic hepatitis B.

Hepatology. 2009 Feb;49(2):700; author reply 701-2. doi: 10.1002/hep.22714.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Focusing on the markers for monitoring and antiviral therapy in chronic hepatitis B virus infection].

Zhonghua Gan Zang Bing Za Zhi. 2006 Nov;14(11):836-7.

Sequential combination therapy for chronic hepatitis B: more challenges to be tackled.

Am J Gastroenterol. 2007 Jul;102(7):1544; author reply 1545. doi: 10.1111/j.1572-0241.2007.01261.x.

[The genetic variability and clinical significance of hepatitis B virus].

Zhonghua Gan Zang Bing Za Zhi. 2009 Mar;17(3):161-3.

[HBV mutations during antiviral therapy in patients with chronic hepatitis B].

Korean J Hepatol. 2005 Dec;11(4):311-9.

Antiviral therapy of chronic hepatitis B.

Antiviral Res. 2006 Sep;71(2-3):206-15. doi: 10.1016/j.antiviral.2006.04.003. Epub 2006 Apr 25.

[Effects of lamivudine and interferon-alpha combination therapy on chronic hepatitis B].

Zhonghua Gan Zang Bing Za Zhi. 2002 Apr;10(2):89.

Events occurring at the time of breakthrough hepatitis during lamivudine treatment for chronic hepatitis B.

J Gastroenterol. 2004 Aug;39(8):813-4. doi: 10.1007/s00535-004-1415-9.

Management of antiviral resistance in patients with chronic hepatitis B.

Antivir Ther. 2004 Oct;9(5):679-93.

[Therapy effects of short-term lamivudine treatment on 22 hepatitis B patients with HBeAg-negative].

Zhonghua Gan Zang Bing Za Zhi. 2003 Apr;11(4):239.

Revisiting the treatment recommendations for chronic hepatitis B.

Hepatology. 2009 Feb;49(2):700; author reply 701-2. doi: 10.1002/hep.22714.

[Focusing on the markers for monitoring and antiviral therapy in chronic hepatitis B virus infection].

作者信息

Wei Lai

机构信息

People's Hospital, Hepatology Institute, Peking University, Beijing 100044, China.

出版信息

Zhonghua Gan Zang Bing Za Zhi. 2006 Nov;14(11):836-7.

PMID:17125613

Abstract

摘要